ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 2 filers reported holding ATYR PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,000 | -41.2% | 28,236 | -6.3% | 0.00% | – |
| Q1 2019 | $17,000 | +13.3% | 30,136 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -37.5% | 30,136 | 0.0% | 0.00% | – |
| Q3 2018 | $24,000 | -11.1% | 30,136 | -0.2% | 0.00% | – |
| Q2 2018 | $27,000 | -66.2% | 30,208 | 0.0% | 0.00% | – |
| Q1 2018 | $80,000 | -31.6% | 30,208 | -10.1% | 0.00% | – |
| Q4 2017 | $117,000 | -33.9% | 33,618 | -4.5% | 0.00% | – |
| Q3 2017 | $177,000 | +48.7% | 35,214 | -0.0% | 0.00% | – |
| Q2 2017 | $119,000 | -3.3% | 35,220 | 0.0% | 0.00% | – |
| Q1 2017 | $123,000 | +179.5% | 35,220 | +71.2% | 0.00% | – |
| Q4 2016 | $44,000 | -31.2% | 20,575 | +1.9% | 0.00% | – |
| Q3 2016 | $64,000 | -73.7% | 20,185 | -67.3% | 0.00% | – |
| Q1 2016 | $243,000 | -60.0% | 61,708 | 0.0% | 0.00% | – |
| Q4 2015 | $607,000 | -4.4% | 61,708 | -0.2% | 0.00% | – |
| Q3 2015 | $635,000 | – | 61,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $6,215,000 | 6.43% |
| EcoR1 Capital, LLC | 2,292,659 | $7,795,000 | 1.38% |
| Rock Springs Capital Management LP | 475,000 | $1,615,000 | 0.08% |
| Quotient Investors, LLC | 22,200 | $77,000 | 0.06% |
| Alyeska Investment Group, L.P. | 839,264 | $2,853,000 | 0.02% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $275,000 | 0.01% |
| Glen Harbor Capital Management LLC | 153,238 | $529,000 | 0.01% |
| Elkfork Partners LLC | 99,154 | $342,000 | 0.01% |
| Meadow Creek Investment Management LLC | 126,196 | $435,000 | 0.01% |
| Tyers Asset Management LLC | 72,112 | $249,000 | 0.01% |